Rang	Name	Position
1	Mr. Steven L. Basta M.B.A.	CEO, President & Director
2	Mr. David A. Socks	Co-Founder
3	Dr. Azmi Nabulsi M.D., M.P.H.	Co-Founder
4	Mr. Sanjeev Narula	Chief Financial & Business Officer
5	Ms. Anne Marie Cook Esq., J.D.	Chief Legal Officer & Corporate Secretary
6	Mr. Jonathan Bentley	Senior VP and Head of Sales, Operations & Training
7	Mr. Robert Breedlove	VP of Finance & Principal Accounting Officer
8	Mr. Eric Sciorilli	Director of Business Development & Investor Relations
9	Mr. Bill Aprea J.D.	Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer
10	Ms. Nancy R. Phelan	Senior Vice President of Marketing & Analytics

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Frazier Life Sciences Management, L.P.	15,41%	104,22 Mio. USD
2	Medicxi Ventures Management (Jersey) Ltd	9,23%	62,40 Mio. USD
3	Amvescap Plc.	5,34%	36,13 Mio. USD
4	BlackRock Inc	5,02%	33,96 Mio. USD
5	The Carlyle Group Inc	4,32%	29,23 Mio. USD
6	Millennium Management LLC	4,17%	28,22 Mio. USD
7	Vanguard Capital Management, LLC	3,19%	21,60 Mio. USD
8	NEA Management Company, LLC	2,42%	16,39 Mio. USD
9	683 Capital Management LLC	2,29%	15,47 Mio. USD
10	Ensign Peak Advisors Inc	2,01%	13,61 Mio. USD
11	Catalys Pacific LLC	1,85%	12,49 Mio. USD
12	GW&K Investment Management, LLC	1,76%	11,88 Mio. USD
13	State Street Corp	1,71%	11,59 Mio. USD
14	Geode Capital Management, LLC	1,64%	11,10 Mio. USD
15	Wasatch Advisors LP	1,62%	10,93 Mio. USD
16	Delaware Management Holdings Inc	1,49%	10,08 Mio. USD
17	Propel Bio Management LLC	1,30%	8,78 Mio. USD
18	SummitTX Capital, L.P	1,23%	8,33 Mio. USD
19	Franklin Templeton Inc	1,23%	8,31 Mio. USD
20	Marshall Wace Asset Management Ltd	1,06%	7,20 Mio. USD